We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOGP
12426
Sound Group
SOGP
$47.1M
$140K ﹤0.01%
1,910
-2,407
-56% -$154K
GENE
12427
CALL
DELISTED
Genetic Technologies Ltd.
GENE
$140K ﹤0.01%
6,580
+360
+6% +$7.26K
EIGR
12428
PUT
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$140K ﹤0.01%
547
-426
-44% -$106K
BIOR
12429
CALL
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$140K ﹤0.01%
157
+87
+124% +$66.5K
TRIT
12430
DELISTED
Triterras, Inc. Class A Ordinary Shares
TRIT
$140K ﹤0.01%
20,179
-188,275
-90% -$1.26M
VCVC
12431
PUT
DELISTED
10X Capital Venture Acquisition Corp
VCVC
$140K ﹤0.01%
14,100
-127,900
-90% -$1.27M
SRAX
12432
PUT
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$140K ﹤0.01%
25,800
+11,800
+84% +$56.8K
BCBP icon
12433
CALL
BCB Bancorp
BCBP
$163M
$139K ﹤0.01%
10,300
-2,000
-16% -$27.6K
KVHI icon
12434
CALL
KVH Industries
KVHI
$145M
$139K ﹤0.01%
11,300
-3,200
-22% -$43.3K
OCSL icon
12435
CALL
Oaktree Specialty Lending
OCSL
$1.14B
$139K ﹤0.01%
+6,916
New +$139K
TDW icon
12436
PUT
Tidewater
TDW
$4.69B
$139K ﹤0.01%
11,500
-13,000
-53% -$173K
VRN
12437
PUT
DELISTED
Veren
VRN
$139K ﹤0.01%
30,700
+19,500
+174% +$81.8K
MTBL
12438
CALL
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$139K ﹤0.01%
+116,000
New +$119K
VHAQ.RT
12439
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
$139K ﹤0.01%
515,383
-5,449
-1% -$1.12K
LVOX
12440
PUT
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$139K ﹤0.01%
16,700
-30,000
-64% -$296K
HZN
12441
DELISTED
Horizon Global Corporation
HZN
$139K ﹤0.01%
16,358
-21,898
-57% -$190K
RTPZ.U
12442
DELISTED
Reinvent Technology Partners Z Units, each consisting of one Class A ordinary share and one-fifth o
RTPZ.U
$139K ﹤0.01%
+13,491
New +$139K
PPBT
12443
Purple Biotech
PPBT
$2.44M
$138K ﹤0.01%
141
-183
-56% -$168K
MKFG
12444
DELISTED
Markforged Holding Corporation
MKFG
$138K ﹤0.01%
+1,387
New +$141K
ADERU
12445
DELISTED
26 Capital Acquisition Corp Unit
ADERU
$138K ﹤0.01%
13,457
-1,118
-8% -$11.3K
CLVR
12446
PUT
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$138K ﹤0.01%
453
-900
-67% -$277K
KDMN
12447
PUT
DELISTED
Kadmon Holdings, Inc.
KDMN
$138K ﹤0.01%
35,700
+19,600
+122% +$76K
CLAS.WS
12448
DELISTED
Class Acceleration Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CLAS.WS
$138K ﹤0.01%
175,220
+220
+0.1% +$136
COCP icon
12449
Cocrystal Pharma
COCP
$21.6M
$137K ﹤0.01%
+9,145
New +$139K
FOCL
12450
PUT
EDAP TMS S.A.
FOCL
$178M
$137K ﹤0.01%
+19,300
New +$140K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.